by Vandana Singh | Mar 2, 2026 | General
Ascendis Pharma A/S (NASDAQ:ASND) shares are up during Monday’s premarket session following the FDA’s approval of Yuviwel (navepegritide; developed as TransCon CNP), the first and only once-weekly treatment for children with achondroplasia. FDA Approval The FDA...
by Avi Kapoor | Mar 2, 2026 | General
On CNBC’s “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked QXO, Inc. (NYSE:QXO) following the release of quarterly earnings. QXO reported fourth-quarter earnings of 2 cents per...
by Avi Kapoor | Mar 2, 2026 | General
Target Corporation (NYSE:TGT) will release earnings for its fourth quarter before the opening bell on Tuesday, March 3. Analysts expect the company to report quarterly earnings of $2.15 per share. That’s down from $2.41 per share in the year-ago period. The consensus...
by Avi Kapoor | Mar 2, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Ascendiant Capital analyst Edward Woo initiated coverage on...
by Kaustubh Bagalkote | Mar 2, 2026 | General
Oil giants and related ETFs rocketed in pre-market action Monday, fueled by Brent crude’s sharp climb on U.S.-Iran hostilities. The weekend killing of Iran’s Supreme Leader Ayatollah Ali Khamenei in joint U.S.-Israeli strikes sent traders scrambling for energy...
Recent Comments